As the head of global research and medical strategy for ViiV Healthcare, Dr. Kimberly Smith oversees the clinical development of pipeline assets in support of the overall company strategy to deliver meaningful advances in treatment and care for people living with HIV.
After joining ViiV in late 2013, Kimberly served as Vice President and Head of Global Medical Strategies prior to her current position. Before her roles in industry, Kimberly was Principal Investigator of the Rush University Medical Center Clinical Research Site of the AIDS Clinical Trials Group (ACTG). She also served as the chair of the ACTG Underrepresented Populations committee and chair of multiple ACTG clinical trials. Kimberly has been a member of NIH study sections, the HIVMA Board of Directors, the CDC Board of Scientific Counsellors, and numerous advisory committees.
Kimberly has published over 100 articles, abstracts and manuscripts, and she edited HIV/AIDS in U.S. Communities of Color, one of the few books that addresses the HIV epidemic among minorities in the U.S.
In addition to her research activities, Kimberly has been an active HIV clinician, clinical educator, community leader, and advocate. She has lectured at countless local national and international conferences including the Conference on Retroviruses and Opportunistic Infections (CROI), the International AIDS Conference, The International Conference on Antimicrobial Agents and Chemotherapy, and the Infectious Disease Society of America.
Kimberly is a graduate of the University of Michigan School of Medicine and also holds a MPH degree from the University of Michigan School of Public Health. She completed her internship, residency, and Infectious Disease fellowship at Rush University Medical Center in Chicago. Following her training she joined the faculty of the Section of Infectious Disease at Rush University Medical Center in Chicago.